Patients infected with human immunodeficiency virus (HIV) are at increased risk for
developing both non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). Even if this …

Kaposi sarcoma—associated herpesvirus infection is associated with the development of 3
proliferative diseases: Kaposi sarcoma, primary effusion lymphoma, and multicentric …

Idiopathic multicentric Castleman disease (iMCD) is a rare and poorly understood
hematologic disorder characterized by lymphadenopathy, systemic inflammation …

Background In HIV cohorts with access to highly active antiretroviral therapy (HAART), the
incidence of Kaposi's sarcoma (KS) is falling; however, the incidence of multicentric …

Kaposi sarcoma herpesvirus (KSHV)–associated multicentric Castleman disease (MCD) is a
lymphoproliferative disorder most commonly observed in HIV-infected patients. It is …

Kaposi sarcoma (KS) herpesvirus–associated multicentric Castleman disease (KSHV-MCD)
is a lymphoproliferative disorder, most commonly seen in HIV-infected patients, that has a …

Although HIV-associated multicentric Castleman disease (HIV-MCD) is not classified as an
AIDS-defining illness, mortality is high and progression to lymphoma occurs frequently. At …

Abstract Human herpesvirus 8 (HHV8) is a gamma herpesvirus associated with Kaposi
sarcoma, multicentric Castleman disease, and primary effusion lymphoma …

HIV-associated plasmablastic multicentric Castleman disease is an increasingly frequent
diagnosis. Kaposi sarcoma herpesvirus is found in the monotypic polyclonal plasmablasts …

HIV-associated multicentric Castleman disease (MCD) is associated with a high risk of
developing nonHodgkin lymphoma (NHL). Rituximab is effective in HIV-MCD, but its impact …